WHO ICTRP trial
Myo-inositol versus clomiphene citrate as first line treatment for ovulation…
EUCTR2018-004604-20-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2018-004604-20-BE |
|---|---|
| Public title | Myo-inositol versus clomiphene citrate as first line treatment for ovulation induction in PCOS |
| Scientific title | Myo-inositol versus clomiphene citrate as first line treatment for ovulation induction in PCOS |
| Primary sponsor | Ghent University Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Belgium |
| Conditions | Polycystic ovary syndrome (PCOS);Therapeutic area: Diseases [C] - Hormonal diseases [C19] |
| Interventions | Trade Name: Clomid, tabletten 50 mg Product Name: Clomid, tabletten 50 mg Pharmaceutical Form: Tablet INN or Proposed INN: CLOMIFENE CITRATE CAS Number: 50-41-9 Other descriptive name: CLOMIFENE CITRATE Concentration unit: mg milligram(s)… |
| Registration date | Oct 14, 2019 |
| Target size | 320 |
| Secondary IDs | AGO/2018/007 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: